Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 6/2011

01.06.2011 | Materno-fetal Medicine

Awareness, knowledge, and use of folic acid among women: a study from Turkey

verfasst von: Zeynep Baykan, Ahmet Öztürk, Serpil Poyrazoğlu, İskender Gün

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the awareness, knowledge, and behaviors relevant to folic acid intake in women aged 15–49 years.

Materials and methods

A questionnaire designed by the researchers was administered to 1,083 women who attended to family health care centers for any reason, between 1 and 15 of December 2009.

Results

Half of the women (53.7%) surveyed did not hear or read about folic acid. Women older than 35 and less-educated women were more unaware of folic acid. Out of 171 pregnant women, 81.3% (139 women) were taking/took vitamin/folic acid supplementation but only 12.2% of the users started to take supplements at least 1 month before conception. Out of 912 non-pregnant women 81 (8.9%) said they are taking any vitamin or mineral supplement. Out of the women who are not pregnant, not using a modern contraceptive method and planning to have a child at the time of the survey, only 9 (10%) were taking vitamin/folic acid. The most common information sources on folic acid were the doctors.

Conclusion

In order to improve the intake of folic acid during the recommended period, preconceptional counseling by the family doctors to inform women of childbearing age about the need to take folic acid to prevent NTDs seems to be important.
Literatur
1.
Zurück zum Zitat Hilton JJ (2007) A comparison of folic acid awareness and intake among young women aged 18–24 years. J Am Acad Nurse Pract 19:516–522PubMedCrossRef Hilton JJ (2007) A comparison of folic acid awareness and intake among young women aged 18–24 years. J Am Acad Nurse Pract 19:516–522PubMedCrossRef
3.
Zurück zum Zitat Melvin EC, George TM, Worley G, Franklin A (2000) Genetic studies in neural tube defects. Pediatr Neurosurg 32:1–9PubMedCrossRef Melvin EC, George TM, Worley G, Franklin A (2000) Genetic studies in neural tube defects. Pediatr Neurosurg 32:1–9PubMedCrossRef
4.
Zurück zum Zitat Unusan N (2004) Assessment of Turkish women’s knowledge concerning folic acid and prevention of birth defects. Public Health Nutr 7(7):851–855PubMedCrossRef Unusan N (2004) Assessment of Turkish women’s knowledge concerning folic acid and prevention of birth defects. Public Health Nutr 7(7):851–855PubMedCrossRef
5.
Zurück zum Zitat Tunçbilek E (2004) The high incidence of neural tube defects in Turkey what should be done for prevention? Turk Pediatr J 47(2):79–84 Tunçbilek E (2004) The high incidence of neural tube defects in Turkey what should be done for prevention? Turk Pediatr J 47(2):79–84
6.
Zurück zum Zitat Eichholzer M, Tonz O, Zimmermann R (2006) Folic acid: a public-health challenge. Lancet 367:1352–1361PubMedCrossRef Eichholzer M, Tonz O, Zimmermann R (2006) Folic acid: a public-health challenge. Lancet 367:1352–1361PubMedCrossRef
7.
Zurück zum Zitat Tunçbilek E, Temel E, Özalp İ, Teziç T, Köse R, Üstündağ M, Haznedaroğlu D, Kaptan H (2002) Genetic diseases. Handbook for health personnel. T.C. Ministry of Health General Directory of Health Project, T.R. Ministry of Health General Directorate of Mother and Child Health and Family Planning, Ankara Tunçbilek E, Temel E, Özalp İ, Teziç T, Köse R, Üstündağ M, Haznedaroğlu D, Kaptan H (2002) Genetic diseases. Handbook for health personnel. T.C. Ministry of Health General Directory of Health Project, T.R. Ministry of Health General Directorate of Mother and Child Health and Family Planning, Ankara
8.
Zurück zum Zitat Abdulrazzaq YM, Al-Gazali LI, Bener A, Hossein M, Verghese M, Dawodu A, Padmanabhan R (2003) Folic acid awareness and intake survey in the United Arab Emirates. Reprod Toxicol 17:171–176PubMedCrossRef Abdulrazzaq YM, Al-Gazali LI, Bener A, Hossein M, Verghese M, Dawodu A, Padmanabhan R (2003) Folic acid awareness and intake survey in the United Arab Emirates. Reprod Toxicol 17:171–176PubMedCrossRef
9.
Zurück zum Zitat Coll O, Pisa S, Palacio M, Quinto L, Cararach V (2004) Awareness of the use of folic acid to prevent neural tube defects n a Mediterranean area. Eur J Obstet Gynecol Reprod Biol 115:173–177PubMedCrossRef Coll O, Pisa S, Palacio M, Quinto L, Cararach V (2004) Awareness of the use of folic acid to prevent neural tube defects n a Mediterranean area. Eur J Obstet Gynecol Reprod Biol 115:173–177PubMedCrossRef
10.
Zurück zum Zitat Sayers GM, Hughes N, Scallan E, Johnson Z (1997) A survey of knowledge and use of folic acid among women of childbearing age in Dublin. J Public Health Med 19:328–332PubMed Sayers GM, Hughes N, Scallan E, Johnson Z (1997) A survey of knowledge and use of folic acid among women of childbearing age in Dublin. J Public Health Med 19:328–332PubMed
11.
Zurück zum Zitat Chivu CM, Tulchinsky TH, Soar es-Weiser K, Braunstein R, Brezis M (2008) A systematic review of interventions to increase awareness, knowledge, and folic acid consumption before and during pregnancy. Am J Health Promot 22(4):237–245PubMedCrossRef Chivu CM, Tulchinsky TH, Soar es-Weiser K, Braunstein R, Brezis M (2008) A systematic review of interventions to increase awareness, knowledge, and folic acid consumption before and during pregnancy. Am J Health Promot 22(4):237–245PubMedCrossRef
12.
Zurück zum Zitat Amitai Y, Fisher N, Haringman M, Meiraz H, Baram N, Leventhal A (2004) Increased awareness, knowledge and utilization of preconceptional folic acid in Israel following a national campaign. Prev Med 39:731–737PubMedCrossRef Amitai Y, Fisher N, Haringman M, Meiraz H, Baram N, Leventhal A (2004) Increased awareness, knowledge and utilization of preconceptional folic acid in Israel following a national campaign. Prev Med 39:731–737PubMedCrossRef
13.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC) (1992) Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR, 41 (RR-14) Centers for Disease Control and Prevention (CDC) (1992) Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR, 41 (RR-14)
14.
Zurück zum Zitat Nawapun K, Phupong V (2007) Awareness of the benefits of folic acid and prevalence of the use of folic acid supplements to prevent neural tube defects among Thai women. Arch Gynecol Obstet 276:53–57PubMedCrossRef Nawapun K, Phupong V (2007) Awareness of the benefits of folic acid and prevalence of the use of folic acid supplements to prevent neural tube defects among Thai women. Arch Gynecol Obstet 276:53–57PubMedCrossRef
15.
Zurück zum Zitat Chan AC, Van Essen P, Scott H, Haan EA, Sage L, Scott J, Gill TK, Nguyen A (2008) Folate awareness and the prevalence of neural tube defects in South Australia, 1966–2007. MJA 189:566–569PubMed Chan AC, Van Essen P, Scott H, Haan EA, Sage L, Scott J, Gill TK, Nguyen A (2008) Folate awareness and the prevalence of neural tube defects in South Australia, 1966–2007. MJA 189:566–569PubMed
16.
Zurück zum Zitat Robbins JM, Hopkins SE, Mosley BS, Casey PH, Cleves MA, Hobbs CA (2006) Awareness and use of folic acid among women in the lower Mississippi delta. J Rural Health 22(3):196–203PubMedCrossRef Robbins JM, Hopkins SE, Mosley BS, Casey PH, Cleves MA, Hobbs CA (2006) Awareness and use of folic acid among women in the lower Mississippi delta. J Rural Health 22(3):196–203PubMedCrossRef
17.
Zurück zum Zitat Turgul Ö, Anlı N, Mandıracıoğlu A, Batı H, Akkol S (2009) The regional campaign for women on awareness of neural tube defects and folic acid in Narlidere, Izmir: a community-based intervention. Eur J Contracept Reprod Health Care 14(1):69–74PubMedCrossRef Turgul Ö, Anlı N, Mandıracıoğlu A, Batı H, Akkol S (2009) The regional campaign for women on awareness of neural tube defects and folic acid in Narlidere, Izmir: a community-based intervention. Eur J Contracept Reprod Health Care 14(1):69–74PubMedCrossRef
18.
Zurück zum Zitat Kondo A, Yamamoto S, Inoue H, Watanabe J, Tada K, Yoshimoto N (2009) Folic acid in the prevention of neural tube defects: Awareness among laywomen and healthcare providers in Japan. Congenit Anom 49:97–101CrossRef Kondo A, Yamamoto S, Inoue H, Watanabe J, Tada K, Yoshimoto N (2009) Folic acid in the prevention of neural tube defects: Awareness among laywomen and healthcare providers in Japan. Congenit Anom 49:97–101CrossRef
19.
Zurück zum Zitat Rasmussen MM, Clemmensen D (2010) Folic acid supplementation in pregnant women. Dan Med Bull 57(1):A4134PubMed Rasmussen MM, Clemmensen D (2010) Folic acid supplementation in pregnant women. Dan Med Bull 57(1):A4134PubMed
20.
Zurück zum Zitat Lantz AG, Edmundson JG, Kisely SR, MacLellan DL (2010) Sources of information for the use of periconceptual folic acid. Public Health 124(4):238–240PubMedCrossRef Lantz AG, Edmundson JG, Kisely SR, MacLellan DL (2010) Sources of information for the use of periconceptual folic acid. Public Health 124(4):238–240PubMedCrossRef
21.
Zurück zum Zitat Petrini JR, Hamner HC, Mulinare J (2008) Use of supplements containing folic acid among women of childbearing age—United States, 2007. MMWR 57:5–8 Petrini JR, Hamner HC, Mulinare J (2008) Use of supplements containing folic acid among women of childbearing age—United States, 2007. MMWR 57:5–8
22.
Zurück zum Zitat Sharp GF, Naylor LA, Cai J, Hyder ML, Chandra P, Guillory VJ (2009) Assessing awareness, knowledge and use of folic acid in Kansas women between the ages of 18 and 44 years. Matern Child Health J 13(6):814–821PubMedCrossRef Sharp GF, Naylor LA, Cai J, Hyder ML, Chandra P, Guillory VJ (2009) Assessing awareness, knowledge and use of folic acid in Kansas women between the ages of 18 and 44 years. Matern Child Health J 13(6):814–821PubMedCrossRef
23.
Zurück zum Zitat Garikapaty VP, Feyerharm R, Zhu B (2008) Folic acid consumption among Missouri women in the periconceptional period. Mo Med 105(6):504–509PubMed Garikapaty VP, Feyerharm R, Zhu B (2008) Folic acid consumption among Missouri women in the periconceptional period. Mo Med 105(6):504–509PubMed
24.
Zurück zum Zitat Paulik E, Császár J, Kozinszky Z, Nagymajtényi L (2009) Preconceptional and prenatal predictors of folic acid intake in Hungarian pregnant women. Eur J Obstet Gynecol Reprod Biol 45(1):49–52CrossRef Paulik E, Császár J, Kozinszky Z, Nagymajtényi L (2009) Preconceptional and prenatal predictors of folic acid intake in Hungarian pregnant women. Eur J Obstet Gynecol Reprod Biol 45(1):49–52CrossRef
Metadaten
Titel
Awareness, knowledge, and use of folic acid among women: a study from Turkey
verfasst von
Zeynep Baykan
Ahmet Öztürk
Serpil Poyrazoğlu
İskender Gün
Publikationsdatum
01.06.2011
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 6/2011
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1547-5

Weitere Artikel der Ausgabe 6/2011

Archives of Gynecology and Obstetrics 6/2011 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Menopausale Hormontherapie für Frauen über 65?

07.05.2024 Klimakterium und Menopause Nachrichten

In den USA erhalten nicht wenige Frauen auch noch im Alter über 65 eine menopausale Hormontherapie. Welche positiven und negativen gesundheitlichen Konsequenzen daraus möglicherweise resultieren, wurde anhand von Versicherungsdaten analysiert.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.